(VIANEWS) – The NASDAQ ended the session with 10x Genomics jumping 10.3% to $38.60 on Wednesday, following the last session’s upward trend. NASDAQ jumped 4.41% to $11,468.00, after three sequential sessions in a row of losses, on what was a very up trend trading session today.

10x Genomics’s last close was $34.99, 80.55% under its 52-week high of $179.89.

About 10x Genomics

10x Genomics, Inc. is a life-science technology company that develops, sells consumables, software, and instruments for analysing biological systems across North America, Europe, Asia Pacific, Africa, China, Middle East, Africa, China, and China. It offers chromium, chromium connect, microfluidic chip, slides, reagents and other consumables. The company’s single-cell solutions run on its chromium instrument. These include single-cell gene expression to measure gene activity cell-by-cell; single-cell Assay for Transposase Accessible Chromati for measuring epigenetics including the physical organization and DNA sequence; single-cell multiome ATAC+ gene expression to measure the epigenetic activity in multiple cells, as well as single-cell gene expression. This allows for the measurement of the gene activity in multiple cells from tens or thousands of them. Visium spatial gene Expression Solution is also offered by the company. This allows you to measure spatial patterns of gene expression across one tissue sample, or combine gene expression with protein co-detection. The company serves many institutions, including academic, government and biopharmaceutical. 10X Technologies, Inc. was the company’s previous name. In November 2014, it changed its name from 10X Genomics, Inc. 10x Genomics, Inc. is an American company that was founded in 2012. Its headquarters are in Pleasanton, California.

Earnings Per Share

As for profitability, 10x Genomics has a trailing twelve months EPS of $-4.17.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.43%.

Yearly Top and Bottom Value

10x Genomics’s stock is valued at $38.60 at 18:25 EST, way under its 52-week high of $179.89 and way above its 52-week low of $23.81.


Today’s last reported volume for 10x Genomics is 857625 which is 31.76% below its average volume of 1256960.

Moving Average

10x Genomics’s value has risen to $29.89 per day, and $51.23 for the 200-day average.

More news about 10x Genomics (TXG).